Michael Decter SemBioSys Genetics Inc. SBS-T TOP PICK Feb 26, 2007

Attempting to make insulin from safflower. Diabetes has become an epidemic. This stock will require some patience and could be volatile. Give it 2 or 3 years.

Michael Decter

Owned

Unlock Rating

$3.150

Stock price when the opinion was issued

biotechnology pharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

PAST TOP PICK

(A Top Pick Feb 26/07. Down 13.7%.) Manufactures insulin out of plants. Succeeding on every measure. Will spike up on news. He is in this one for the longer haul. Still likes.

SELL

Likes the company but doesn't like what has happened to the entire biotech sector. Has largely exited the stock.

Most Recent Experts

Javed Mirza

Raymond James

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Robert McWhirter

Selective Asset Management

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Stockchase Insights

5i Research

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Michael Decter SemBioSys Genetics Inc. SBS-T TOP PICK Feb 26, 2007

You might be interested:

SemBioSys Genetics Inc.(SBS-T)

SemBioSys Genetics Inc.(SBS-T)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals